Consensus on the treatment of dysphagia in Parkinson's disease.

Consensus Deglutition Disorders / etiology Humans Italy Parkinson Disease / complications
Consensus development conference Deglutition disorders Nutrition Parkinson's disease Rehabilitation

Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Nov 2021
Historique:
received: 18 08 2021
revised: 20 09 2021
accepted: 24 09 2021
pubmed: 9 10 2021
medline: 17 11 2021
entrez: 8 10 2021
Statut: ppublish

Résumé

Dysphagia is common in Parkinson's disease (PD). The effects of antiparkinsonian drugs on dysphagia are controversial. Several treatments for dysphagia are available but there is no consensus on their efficacy in PD. To conduct a systematic review of the literature and to define consensus statements on the treatment of dysphagia in PD and related nutritional management. A multinational group of experts in the field of neurogenic dysphagia and/or Parkinson's disease conducted a systematic evaluation of the literature and reported the results according to PRISMA guidelines. The evidence from the retrieved studies was analyzed and discussed in a consensus conference organized in Pavia, Italy, and the consensus statements were drafted. The final version of statements was subsequently achieved by e-mail consensus. The literature review retrieved 64 papers on treatment and nutrition of patients with PD and dysphagia, mainly of Class IV quality. Based on the literature and expert opinion in cases where the evidence was limited or lacking, 26 statements were developed. The statements developed by the Consensus panel provide a guidance for a multi-disciplinary treatment of dysphagia in patients with PD, involving neurologists, otorhinolaryngologists, gastroenterologists, phoniatricians, speech-language pathologists, dieticians, and clinical nutritionists.

Sections du résumé

BACKGROUND BACKGROUND
Dysphagia is common in Parkinson's disease (PD). The effects of antiparkinsonian drugs on dysphagia are controversial. Several treatments for dysphagia are available but there is no consensus on their efficacy in PD.
OBJECTIVE OBJECTIVE
To conduct a systematic review of the literature and to define consensus statements on the treatment of dysphagia in PD and related nutritional management.
METHODS METHODS
A multinational group of experts in the field of neurogenic dysphagia and/or Parkinson's disease conducted a systematic evaluation of the literature and reported the results according to PRISMA guidelines. The evidence from the retrieved studies was analyzed and discussed in a consensus conference organized in Pavia, Italy, and the consensus statements were drafted. The final version of statements was subsequently achieved by e-mail consensus.
RESULTS RESULTS
The literature review retrieved 64 papers on treatment and nutrition of patients with PD and dysphagia, mainly of Class IV quality. Based on the literature and expert opinion in cases where the evidence was limited or lacking, 26 statements were developed.
CONCLUSIONS CONCLUSIONS
The statements developed by the Consensus panel provide a guidance for a multi-disciplinary treatment of dysphagia in patients with PD, involving neurologists, otorhinolaryngologists, gastroenterologists, phoniatricians, speech-language pathologists, dieticians, and clinical nutritionists.

Identifiants

DOI: 10.1016/j.jns.2021.120008 PMID: 34624796
pubmed: 34624796
pii: S0022-510X(21)02704-0
doi: 10.1016/j.jns.2021.120008
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

120008

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Antonio Schindler (A)

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy.

Nicole Pizzorni (N)

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy. Electronic address: nicole.pizzorni@unimi.it.

Emanuele Cereda (E)

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Giuseppe Cosentino (G)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; Clinical Neurophysiology Unit, IRCCS Mondino Foundation, Pavia, Italy.

Micol Avenali (M)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy.

Cristina Montomoli (C)

Department of Public Health, Experimental and Forensic Medicine, Unit of Biostatistics and Clinical Epidemiology, University of Pavia, Pavia, Italy.

Giovanni Abbruzzese (G)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal Child Health, University of Genoa-IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Angelo Antonini (A)

Parkinson and Movement Disorders Unit, Center for Neurodegenerative Diseases (CENSE), Department of Neuroscience, University of Padua, Padua, Italy.

Filippo Barbiera (F)

Azienda Sanitaria Provinciale Agrigento - UO Complessa Radiologia Distretto Ag 2 Sciacca-Ribera, Presidio Ospedaliero di Sciacca (AG), Sciacca, Agrigento, Italy.

Marco Benazzo (M)

Department of Otolaryngology Head Neck Surgery, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

Eduardo Benarroch (E)

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Giulia Bertino (G)

Department of Otolaryngology Head Neck Surgery, University of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

Pere Clavè (P)

Gastrointestinal Physiology Laboratory, Hospital de Mataró, Universitat Autónoma de Barcelona, Mataró, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Instituto de Salud Carlos III, Barcelona, Spain.

Pietro Cortelli (P)

IRCCS, Istituto di Scienze Neurologiche di Bologna, Bologna, Italy; DIBINEM, University of Bologna, Italy.

Roberto Eleopra (R)

Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Chiara Ferrari (C)

Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy.

Shaheen Hamdy (S)

Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Salford Royal Hospital, Salford, UK.

Maggie-Lee Huckabee (ML)

Department of Communication Disorders, Rose Centre for Stroke Recovery and Research, University of Canterbury, Christchurch, New Zeland.

Leonardo Lopiano (L)

Department of Neuroscience "Rita Levi Montalcini", University of Torino, Italy.

Rosario Marchese-Ragona (R)

ENT Department, University of Padova, Padua, Italy.

Stefano Masiero (S)

Rehabilitation Unit, Department of Neuroscience, University of Padova, Padua, Italy.

Emilia Michou (E)

Department of Speech and Language Therapy, School of Health Rehabilitation Sciences, University of Patras, Patras, Greece.

Antonio Occhini (A)

Azienda Sanitaria Provinciale Agrigento - UO Complessa Radiologia Distretto Ag 2 Sciacca-Ribera, Presidio Ospedaliero di Sciacca (AG), Sciacca, Agrigento, Italy.

Claudio Pacchetti (C)

Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.

Ronald F Pfeiffer (RF)

Department of Neurology, Oregon Health and Science University, Portland, OR, USA.

Domenico A Restivo (DA)

Department of Neurology, Garibaldi Hospital, Catania, Italy.

Mariangela Rondanelli (M)

Department of Public Health, Experimental and Forensic Medicine, Unit of Human and Clinical Nutrition, University of Pavia, Pavia, Italy; IRCCS Mondino Foundation, Pavia, Italy.

Giovanni Ruoppolo (G)

Department of Sense Organs, Sapienza University of Rome, Rome, Italy.

Giorgio Sandrini (G)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.

Anthony Schapira (A)

Department of Clinical and Movement Neurosciences, UCL, Queen Square Institute of Neurology, London, UK.

Fabrizio Stocchi (F)

University and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy.

Eduardo Tolosa (E)

Parkinson disease and Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED:CB06/05/0018-ISCIII) Barcelona, Spain.

Francesca Valentino (F)

Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.

Mauro Zamboni (M)

Department of Medicine, Division of Geriatrics, Healthy Aging Center, University of Verona, Italy.

Roberta Zangaglia (R)

Parkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.

Mario Zappia (M)

Department GF Ingrassia, University of Catania, Catania, Italy.

Cristina Tassorelli (C)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy.

Enrico Alfonsi (E)

Clinical Neurophysiology Unit, IRCCS Mondino Foundation, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Consensus on the treatment of dysphagia in...
questionsmedicales.fr › Maladies oto-rhino-laryngologiques › Maladies du pharynx › Troubles de la déglutition › Consensus on the treatment of dysphagia in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Consensus on the treatment of dysphagia in...
questionsmedicales.fr › Régions géographiques › Europe › Italie › Consensus on the treatment of dysphagia in...
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Maladie de Parkinson › Consensus on the treatment of dysphagia in...